Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351559 · ClinicalTrials.gov registry record · NA
IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection
A NA study, sponsored by XDx.
- Completed
- Registry status
- NA
- Development phase
- 629
- Enrollment target
NCT00351559: Completed NA study, sponsored by XDx.
NCT00351559 is a NA study that has completed, run by XDx. The registered enrollment target is 629 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351559, a NA study, has completed, sponsored by XDx.
- COMPLETED
- Registry status
- NA
- Development phase
- 629 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.
Interventions
- DEVICE AlloMap molecular expression testing
- PROCEDURE Right ventricular endomyocardial biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 629 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00351559 record still lists
NCT00351559 is an interventional study that assigns participants to a tested intervention. The registered 629 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 2 interventions - of which AlloMap molecular expression testing is the first listed.
NCT00351559 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00351559 about?
NCT00351559 is a clinical study titled "IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection". This study is designed to evaluate the safety and efficacy of a leukocyte gene expression profiling method in the monitoring of asymptomatic heart transplant patients for acute rejection.
What is the current status of trial NCT00351559?
This trial is currently completed. It is a NA study. The enrollment target is 629 participants. The study started on 2005-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00351559?
The interventions under investigation include: AlloMap molecular expression testing (DEVICE), Right ventricular endomyocardial biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00351559?
This trial is sponsored by XDx, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00351559's enrollment target sits among peer trials
629 160th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia